Helix BiopharmaHBP 
$0.670.00%24h
0.00%24h
Global rank17922
Market cap$130.01M
Change 7d-1.02%
YTD Performance-
SP500 benchmark
P/E-22.43
P/S0
Revenue$0
Earnings-$4.36M
Dividend yield-
Main Sector
Healthcare
Helix Biopharma (HBP) Total Liabilities
HBP Total Liabilities in 2022: $1.30M
According to Helix Biopharma latest financial reports the total liabilities of HBP is $1.30M, an decrease of -45.11% to 2022. At the end of 2022 company had $2.37M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Helix Biopharma is responsible for during its operational activities.
Helix Biopharma (HBP) Total Liabilities History from 2023 to 2022
-
Value:-
HBP Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $1.30M | -45.11% |
| 2022 | $2.37M | -37.49% |
| 2021 | $3.79M | 183.53% |
| 2020 | $1.34M | -39.16% |
| 2019 | $2.19M | - |
View the Top Total Liabilies Stocks
